Care Transitions in Anticoagulation Management for Patients With Atrial Fibrillation: An Emphasis on Safety | Ochsner Journal
Dabigatran, rivaroxaban, or apixaban versus enoxaparin for thromboprophylaxis after total hip or knee replacement: systematic review, meta-analysis, and indirect treatment comparisons | The BMJ
Guidance on converting between anticoagulants
Anticoagulants | Health Navigator NZ
Safety Profile - DVT & PE Initial Treatment | XARELTO® (rivaroxaban) HCP
Xarelto® - Responsible Use
Guideline for the Prescribing of Novel Oral Anticoagulants (NOACs): Dabigatran (Pradaxa ), Rivaroxaban (Xarelto ), Apixaban (Eliquis ) - PDF Free Download
RBCP - Cost comparison between enoxaparin and new oral anticoagulants dabigatran and rivaroxaban in venous thromboembolism prophylaxis
Transitioning Between Anticoagulants Continuous Infusion Unfractionated Heparin (UFH) SC LMWH or Fondaparinux Rivaroxaban (Xarel
Apixaban starting dose after 1 week LMWH therapy (PE or DVT)? | ResearchGate
Direct Oral Anticoagulant Use: A Practical Guide to Common Clinical Challenges | Journal of the American Heart Association
![PDF] Thromboprophylactic treatment with rivaroxaban or dabigatran compared with enoxaparin or dalteparin in patients undergoing elective hip- or knee replacement surgery | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/c3bd71fdf61b8f8bdc9321c5d380254016ae03ea/20-Table1-1.png "PDF] Thromboprophylactic treatment with rivaroxaban or dabigatran compared with enoxaparin or dalteparin in patients undergoing elective hip- or knee replacement surgery | Semantic Scholar")
PDF] Thromboprophylactic treatment with rivaroxaban or dabigatran compared with enoxaparin or dalteparin in patients undergoing elective hip- or knee replacement surgery | Semantic Scholar
Aspirin and an oral anticoagulant – can they be used together? - NPS MedicineWise
Treatment Considerations | XARELTO® (rivaroxaban) HCP
Dose of XARELTO for Switching From Another Anticoagulant During Initial DVT or PE Treatment
Time for a change? Switching anticoagulants in patients with AF or VTE | Thrombosis Adviser
Effectiveness and Safety of Standard- and Low-Dose Rivaroxaban in Asians With Atrial Fibrillation - ScienceDirect
Transition of Anticoagulants 2014
Rivaroxaban: a fully-subsidised oral anticoagulant
Anticoagulation Strategies in Patients With Cancer: JACC Review Topic of the Week - ScienceDirect
Pharmacokinetic and pharmacodynamic evaluation of rivaroxaban: considerations for the treatment of venous thromboembolism | Thrombosis Journal | Full Text
Guidance on Converting Between Anticoagulants
